Proteome- and Transcriptome-Wide Genetic Analysis Identifies Biological Pathways and Candidate Drug Targets for Preeclampsia
Circulation: Genomic and Precision Medicine · 2024-10 · 17 (5)
DOI: 10.1161/circgen.124.004755 ↗Kurz gefasst
Fachartikel in der Zeitschrift Circulation: Genomic and Precision Medicine, 2024-10. Verfasst von Maddalena Ardissino und 13 weiteren Autor:innen. Beteiligte Einrichtung: British Heart Foundation Cardiovascular Epidemiology Unit, Department of Public Health and Primary Care (M.A., L.G., A.B.), University of Cambridge, …. Hauptthemen laut MEDLINE: Pre-Eclampsia, Genome-Wide Association Study, Transcriptome, Molecular Targeted Therapy. Die Arbeit wurde bisher 15-mal zitiert (Crossref) und nennt 62 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NHLBI NIH HHS, British Heart Foundation, NHGRI NIH HHS.
Abstract (Originalsprache)
BACKGROUND: Preeclampsia is a leading cause of maternal and perinatal morbidity and mortality. However, the current understanding of its underlying biological pathways remains limited. METHODS: In this study, we performed a cross-platform proteome- and transcriptome-wide genetic analysis aimed at evaluating the causal relevance of >2000 circulating proteins with preeclampsia, supported by data on the expression of over 15 000 genes across 36 tissues leveraging large-scale preeclampsia genetic association data from women of European ancestry. RESULTS: We demonstrate genetic associations of 18 circulating proteins with preeclampsia (SULT1A1 [sulfotransferase 1A1], SH2B3 [SH2B adapter protein 3], SERPINE2 [serpin family E member 2], RGS18 [regulator of G-protein signaling 18], PZP [pregnancy zone protein], NOTUM [notum, palmitoleoyl-protein carboxylesterase], METAP1 [methionyl aminopeptidase 1], MANEA [mannosidase endo-alpha], jun-D [JunD proto-oncogene], GDF15 [growth differentiation factor 15], FGL1 [fibrinogen like 1], FGF5 [fibroblast growth factor 5], FES [FES proto-oncogene], APOBR [apolipoprotein B receptor], ANP [natriuretic peptide A], ALDH-E2 [aldehyde dehydrogenase 2 family member], ADAMTS13 [ADAM metallopeptidase with thrombospondin type 1 motif 13], and 3MG [N-methylpurine DNA glycosylase]), among which 11 were either directly or indirectly supported by gene expression data, 9 were supported by Bayesian colocalization analyses, and 5 (SERPINE2, PZP, FGF5, FES, and ANP) were supported by all lines of evidence examined. Protein interaction mapping identified potential shared biological pathways through natriuretic peptide signaling, blood pressure regulation, immune tolerance, and thrombin activity regulation. CONCLUSIONS: This investigation identified multiple targetable proteins linked to cardiovascular, inflammatory, and coagulation pathways, with SERPINE2, PZP, FGF5, FES, and ANP identified as pivotal proteins with likely causal roles in the development of preeclampsia. The identification of these potential targets may guide the development of targeted therapies for preeclampsia.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- British Heart Foundation Cardiovascular Epidemiology Unit, Department of Public Health and Primary Care (M.A., L.G., A.B.), University of Cambridge, United Kingdom.
- Victor Phillip Dahdaleh Heart and Lung Research Institute (M.A, A.B.), University of Cambridge, United Kingdom.
- National Heart and Lung Institute (M.A, F.S.N.), Imperial College London, United Kingdom.
- Medical Research Council, London Institute of Medical Sciences (M.A.), Imperial College London, United Kingdom.
- Program in Medical and Population Genetics and Cardiovascular Disease Initiative (B.T., A.S., P.N., M.C.H.).
- Center for Genomic Medicine and Cardiovascular Research Center, Massachusetts General Hospital, Harvard Medical School, Boston (B.T., A.S., P.N., M.C.H.).
ORCID-Profile: Maddalena Ardissino, Buu Truong, Eric A W Slob, Satoshi Yoshiji, Alec P Morley, Stephen Burgess, Fu Siong Ng, Antonio de Marvao, Pradeep Natarajan, Kypros Nicolaides, Adam Butterworth, Michael C Honigberg
Förderung
- NHLBI NIH HHS
- British Heart Foundation
- NHGRI NIH HHS
- Wellcome Trust
Zitieren
APA
Ardissino, M., Truong, B., Slob, E. A. W., Schuermans, A., Yoshiji, S., Morley, A. P., Burgess, S., Ng, F. S., de Marvao, A., Natarajan, P., Nicolaides, K., Gaziano, L., Butterworth, A., & Honigberg, M. C. (2024). Proteome- and Transcriptome-Wide Genetic Analysis Identifies Biological Pathways and Candidate Drug Targets for Preeclampsia. Circulation: Genomic and Precision Medicine, 17(5). https://doi.org/10.1161/circgen.124.004755
Vancouver
Ardissino M, Truong B, Slob EAW, Schuermans A, Yoshiji S, Morley AP, et al. Proteome- and Transcriptome-Wide Genetic Analysis Identifies Biological Pathways and Candidate Drug Targets for Preeclampsia. Circulation: Genomic and Precision Medicine. 2024;17(5). doi:10.1161/circgen.124.004755
BibTeX
@article{Ardissino2024,
author = {Ardissino, Maddalena and Truong, Buu and Slob, Eric A W and Schuermans, Art and Yoshiji, Satoshi and Morley, Alec P and Burgess, Stephen and Ng, Fu Siong and de Marvao, Antonio and Natarajan, Pradeep and Nicolaides, Kypros and Gaziano, Liam and Butterworth, Adam and Honigberg, Michael C},
title = {Proteome- and Transcriptome-Wide Genetic Analysis Identifies Biological Pathways and Candidate Drug Targets for Preeclampsia},
journal = {Circulation: Genomic and Precision Medicine},
year = {2024},
volume = {17},
number = {5},
doi = {10.1161/circgen.124.004755}
}
EUVIMED